Novo Holdings creates HemabDanish Novo Holdings has founded Hemab ApS that is focussed on fighting orphan bleeding disorders by bi-specific antibodies. more ➔
Biotech companies launch Biotech AustriaAustria has needed a biotech association for a long time. In just two months, entrepreneurs have launched Biotech Austria. more ➔
How microplastic particles get into the body Weathered microplastic particles may pose a greater risk than pristine ones, suggests a study of German researchers on mouse cells. more ➔
Centogene and Anylam launch clinical programmeDiagnostics developer Centogene NV and Alnylam Pharmaceuticals launched a clinical programme aimed at improving ATTRv diagnosis. more ➔
Avantium NV bags money for demo plantGreen chemistry company Avantium NV has secured a €7.5m funding from the National Programme Groningen to support the construction of a 5 kilotonnes FDCA plant. more ➔
How stress brings cancer to life againStress hormones such as cortisol or norephidrine can reawaken dormant tumour cells, a research team led by AstraZeneca has found out. more ➔
UK approves Biontech/Pfizer Covid-19 vaccine (copy 1)Biontech and Pfizer have received emergency approval for their COVID-19 vaccine in the UK. Mass immunization could start next week, the first in Western countries. more ➔
UK approves Biontech/Pfizer Covid-19 vaccineBiontech and Pfizer have received emergency approval for their COVID-19 vaccine in the UK. Mass immunization could start next week, the first in Western countries. more ➔
Swiss Noema Pharma raises CHF54m in Series A financingNoema Pharma AG kicks off with CHF54m and licenced drug candidates from Roche AG. more ➔
Germany first EU country to launch COVID-19 therapy offensive?After months of lobbying by the BIOM biotech cluster, Bavaria is launching a €50m initiative to push the best and fastest COVID-19 therapies. more ➔
